Wang Mengkun, Li Yifei, Lei Jie, Jiang Huiyi
Department of Pediatrics, Children's Medical Center, The First Hospital of Jilin University, Lequn Branch, No. 3302 Jilin Road, Changchun, 130021, China.
Sci Rep. 2025 Jan 3;15(1):709. doi: 10.1038/s41598-024-84838-7.
The global spread of the novel coronavirus disease 2019, caused by SARS-CoV-2 virus, impacts individuals of all age groups, including lactating women and children. Concerns have been raised regarding the potential transmission of SARS-CoV-2 from mother to child, following the discovery of SARS-CoV-2 RNA in human milk. Therefore, this study aims to investigate whether the Omicron novel coronavirus variants are transmitted through human milk. This study was conducted between March and May 2022 at Children's Medical Center, the First Hospital of Jilin University, Lequn Branch. Fourteen lactating mothers and their breastfed children hospitalized with COVID-19 (Omicron variant) formed mother-child pairs, which constituted the test group. Additional 11 non-breastfed children of the same age hospitalized with COVID-19 (Omicron variant) participated in the study as the control group. Their clinical manifestations were observed, and the milk of lactating mothers with COVID-19 was collected for SARS-CoV-2 RNA detection. Milk samples from each lactating mother were collected consecutively for 2-18 days and subjected to polymerase chain reaction (PCR) testing forSARS-CoV-2 RNA detection. The time span for sample collection ranged from admission to discharged. The symptoms observed in mothers and children infected with the Omicron variant of COVID-19 were primary upper respiratory tract infection, with fever and cough being the main clinical manifestations. In total, 104 breast milk samples were collected from 14 lactating mothers with COVID-19, and all samples were negative for SARS-CoV-2 RNA. This study found no evidence of Omicron variants transmission through breast milk and accepts the safety of breastfeeding for novel coronavirus-positive mothers when contact precautions are taken. Our findings provide additional support for recommendations that lactating women with COVID-19 continue to breastfeed while taking precautions.
由严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)引起的2019年新型冠状病毒病在全球传播,影响所有年龄组的人群,包括哺乳期妇女和儿童。在人乳中发现SARS-CoV-2 RNA后,人们对SARS-CoV-2从母亲传播给孩子的可能性表示担忧。因此,本研究旨在调查奥密克戎新型冠状病毒变异株是否通过人乳传播。本研究于2022年3月至5月在吉林大学第一医院乐群分院儿童医学中心进行。14对因感染新冠病毒(奥密克戎变异株)住院的哺乳期母亲及其母乳喂养的孩子组成母婴对,构成试验组。另外11名因感染新冠病毒(奥密克戎变异株)住院的同年龄非母乳喂养儿童作为对照组参与研究。观察他们的临床表现,并收集感染新冠病毒的哺乳期母亲的乳汁进行SARS-CoV-2 RNA检测。对每位哺乳期母亲的乳汁样本连续收集2至18天,并进行聚合酶链反应(PCR)检测以检测SARS-CoV-2 RNA。样本收集的时间跨度从入院到出院。感染新冠病毒奥密克戎变异株的母亲和孩子出现的症状主要是上呼吸道感染,发热和咳嗽是主要临床表现。共从14名感染新冠病毒的哺乳期母亲中收集了104份母乳样本,所有样本的SARS-CoV-2 RNA检测均为阴性。本研究未发现奥密克戎变异株通过母乳传播的证据,并认可在采取接触预防措施的情况下,新冠病毒呈阳性的母亲进行母乳喂养的安全性。我们的研究结果为新冠病毒感染的哺乳期妇女在采取预防措施的同时继续母乳喂养的建议提供了更多支持。